Published in Vaccine Weekly, March 14th, 2001
"The heptavalent pneumococcal polysaccharide-CRM197 conjugate vaccine is safe and efficacious in the prevention of acute otitis media caused by serotypes included in the vaccine," reported T. Kilpi and associates at the National Public Health Institute in Finland.
Kilpi et al. chose 1,662 infants at random to receive either the vaccine or a hepatitis B vaccine (to compare side effects) at two, four, six, and 12 months of age. They recorded episodes of ear infections verified by clinical and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly